ARC protects cochlear hair cells from neomycin-induced ototoxicity via the Ras/JNK signaling pathway

Xiaoyu Yu1, Hanbing Gao2, Jie Zhang3

  • 1Department of Otolaryngology, Hangzhou First People's Hospital, School of Medicine, Affiliated to Westlake University, Hangzhou, Zhejiang, China; The Fourth school of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.

Toxicology Letters
|December 12, 2024
PubMed

Insights

Apoptosis repressor with caspase recruitment domain (ARC) protects hair cells from neomycin damage by reducing apoptosis via the Ras/JNK pathway. This offers new strategies for preventing drug-induced ototoxicity and cochlear hair cell death.

Area of Science:

  • Ototoxicity research
  • Cellular and molecular biology
  • Signaling pathways

Background:

  • Neomycin is a common ototoxic drug causing hair cell damage.
  • Apoptosis repressor with caspase recruitment domain (ARC) is a key protein in cell survival.
  • Understanding ARC's role in hair cell protection is crucial for treating hearing loss.

Purpose of the Study:

  • To investigate the protective role and mechanism of ARC against neomycin-induced hair cell damage.
  • To explore the involvement of the Ras/JNK signaling pathway in ARC-mediated protection.
  • To provide insights into preventing drug-induced ototoxicity.

Main Methods:

  • Utilized HEI-OC1 cells and basilar membrane cultures for experiments.
  • Employed plasmid transfection to modulate ARC and Ras expression.
  • Assessed cell viability, apoptosis, cleaved caspase-3, p-CREB, and p-c-Jun levels.

Main Results:

  • ARC overexpression enhanced HEI-OC1 cell viability and reduced apoptosis post-neomycin treatment.
  • Cleaved caspase-3 levels decreased, while p-CREB increased and p-c-Jun decreased in ARC-overexpressing cells.
  • Ras and JNK inhibition reduced ARC expression; Ras overexpression increased ARC expression.

Conclusions:

  • ARC protects hair cells from neomycin-induced apoptosis through the Ras/JNK signaling pathway.
  • ARC acts as a protective factor against neomycin-induced ototoxicity.
  • Findings suggest potential therapeutic strategies targeting ARC for cochlear hair cell preservation.